Long-Acting Injectables Transform HIV Prevention and Treatment

Long-acting injectable medications are transforming HIV prevention and treatment, offering a significant alternative to daily pills. Approved by the EMA and FDA, these injectables like cabotegravir and rilpivirine provide convenient dosing options for individuals at risk or living with HIV, enhancing adherence and reducing stigma. Discover how these innovative therapies are paving the way for improved health outcomes in the fight against HIV.